Veranstaltungsarchiv
Colloquium Molekulare Medizin: "Molecular mechanisms regulating B cell survival in health and disease."
Referent: Prof. Dr. Idit Shachar;
Department of Immunology, The Weizmann Institute of Science; Rehovot, Isreal
Colloquium Molekulare Medizin: “Technology driven changes of perspectives in Pathology”
Referent: Univ.-Prof. Dr. med. univ. Dr. sc. nat. Johannes Haybäck, Direktor Institut für Pathologie am Universitätsklinikum Magdeburg
ENTFÄLLT: Colloquium Molekulare Medizin: "Cell Death, Inflammation and the Defense of Tissue Homeostasis"
Referent: Prof. Dr. Pascal Meier;
Institute of Cancer Research, London/UK
Colloquium Molekulare Medizin: “Nephrons and podocytes: what are the numbers telling us?”
Referent: Prof. John Bertram;
Monash University, Melbourne, Australia
Colloquium Molekulare Medizin: "Renale Regeneration: Physiologie und Pathophysiologie"
Referent: Prof. Dr. med. Christian Hugo;
Head, Division of Nephrology,
Universitätsklinikum Carl Gustav Carus
an der Technischen Universität Dresden
Colloquium Molekulare Medizin: “Adiponectin and its role in human disease”
Referent: Dr. Lionel Hebbard,
Centre for Biodiscovery and Molecular Development of Therapeutics, Comparative Genomics Centre; James Cook University, Australia
Colloquium Molekulare Medizin:
Referent: Prof. Dr. Helen Liapis; Pathologist at Arkana Laboratories; Retired Professor of Pathology and Immunology Washington; University School of Medicine, St. Louis, MO; Past Professor of Internal Medicine (Nephrology); Section Head Renal Pathology; C
Colloquium Molekulare Medizin: "Two-photon based functional imaging of cholestatic liver disease"
Referent: Prof. Dr. med. Jan G. Hengstler, Leitung des Forschungsbereichs Toxikologie / Systemtoxikologie, Leibniz-Institut für Arbeitsforschung an der TU Dortmund
Colloquium Molekulare Medizin: “Clinical research in Hepatology: The Belgian perspective”
Referent: Prof. Dr. Frederik Nevens
Head of Clinic, Department Gastroenterology and Hepatology, Division Hepatology-Liver Transplantation University Hospitals Leuven, KU Leuven
Colloquium Molekulare Medizin:
Referent: Prof. Dr. med. Verena Keitel-Anselmino
Oberärztin an der Klinik für Gastroenterologie, Hepatologie und Infektiologie,
Heinrich Heine Universität Düsseldorf
Colloquium Molekulare Medizin: PDGF receptor mutations in tumors and neurological diseases
Referent: Prof. Jean-Baptiste Demoulin
De Duve Institute & Faculty of Pharmacy and Biomedical Sciences
University of Louvain – UCL
Colloquium Molekulare Medizin: "IL-6 Signaling in Inflammation and Cancer"
Referent: Prof. Dr. Stefan Rose-John Director,
Department of Biochemistry
Christian-Albrechts-Universität zu Kiel
Colloquium Molekulare Medizin: Polycystic Kidney Disease: Role of Crystals in Disease Progression"
Referent: Prof. Thomas Weimbs,
PhD Department of Molecular, Cellular & Developmental Biology And Neuroscience Research
Institute, University of California Santa Barbara
Colloquium Molekulare Medizin: Exhaustion of antiviral T cells in human infection: What drives it? And is there a way back?
Referent: Prof. Dr. Georg Lauer, Associate Professor of Medicine
Gastrointestinal Unit
Massachusetts General Hospital
Harvard Medical School
Colloquium Molekulare Medizin: Therapeutic angiogenesis for the renal microcirculation: Small vessels, big role
Referent: Prof. Alejandro R. Chade,
Professor of Physiology and Radiology,
University of Mississippi
3. Bonner Hepatologie Gespräch
Universitätsklinikum Bonn
Montag, 24. Oktober 2016
Biomedizinisches Zentrum
Colloquium Molekulare Medizin: Endothelial nanomechanics as indicator for vascular function/dysfunction
COLLOQUIUM MOLEKULARE MEDIZIN
Am Mittwoch, den 05. Oktober 2016 um 16:30 Uhr
spricht: PD Dr. rer....
Colloquium Molekulare Medizin: Progression of Chronic Kidney Disease - Beyond the Glomerulus
Referent:
Prof. Agnes B. Fogo, MD
Dept. of Pathology, Microbiology and Immunology
Dept. of Medicine and Pediatrics
Vanderbilt University School of Medicine, Nashville, TN, USA
Activation and differentiation of human innate lymphoid cells (ILCs)
Referent:
Dr. Chiara Romagnani, M.D., Ph.D,
Group Leader – Innate Immunity Deutsches Rheuma Forschungszentrum Berlin
Thema:
Activation and differentiation of human innate lymphoid cells (ILCs